Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
This locus encodes a subunit of ATP-dependent chromatin-remodeling complexes. Additionally we are shipping Polybromo 1 Proteins (12) and Polybromo 1 Kits (3) and many more products for this protein.
Showing 10 out of 41 products:
Human Polyclonal PBRM1 Primary Antibody for ICC, IF - ABIN256705
Burrows, Smogorzewska, Elledge: Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. in Proceedings of the National Academy of Sciences of the United States of America 2010
Show all 3 Pubmed References
Human Polyclonal PBRM1 Primary Antibody for IP - ABIN256704
Niimi, Chambers, Downs, Lehmann: A role for chromatin remodellers in replication of damaged DNA. in Nucleic acids research 2012
Knockdown of PBRM1 in colon cancer cells increased the expression of two receptor genes (RIG-I (show DDX58 Antibodies) and MDA5 (show IFIH1 Antibodies)) and upregulated interferon (show IFNA Antibodies) (IFN)-related and inflammation-related gene signatures. Lower PBRM1 expression was associated with advanced pathological grade and poorer survival of colorectal cancer (CRC (show CALR Antibodies)) patients, indicating that PBRM1 could serve as a potential prognostic biomarker for CRC (show CALR Antibodies).
kidney-specific deletion of Vhl (show VHL Antibodies) and Pbrm1, but not either gene alone, results in bilateral, multifocal, transplantable clear cell kidney cancers.
PBRM1 mutation is associated with small Cell Lung Cancer.
These findings indicate that PBRM1 alters cell cycle progression and inhibits proliferation and migration of renal cell carcinoma (show MOK Antibodies) ACHN (show LARP6 Antibodies) cells through the chemokine/chemokine (show CCL1 Antibodies) receptor pathway.
our integrative analysis suggested that methylation and miRNA alterations were likely the downstream events associated with PBRM1 truncation mutations. In summary, this study provided some important insights into the understanding of tumorigenesis driven by PBRM1 truncated mutations in Clear cell renal cell carcinoma (show MOK Antibodies) (ccRCC). The approach may be applied to many driver genes in various cancers.
BAP1 (show RNF2 Antibodies) and PBRM1 loss is seen frequently in intrahepatic cholangiocarcinoma
PBRM1 gene deletion is associated with chordoma.
conclude that four of the BDs act together to target PBRM1 to sites on chromatin; when a single BD is mutated, PBRM1 no longer controls gene expression properly, leading to increased cell proliferation
Synthetic lethality screening identifies TIP60 (show KAT5 Antibodies)-dependent radiation sensitivity in the absence of BAF180.
Functionally, suppression of PBRM1 expression promoted cell proliferation and cell cycle progression
Data suggest BAF180 protein as a critical regulator of cellular senescence and HSC (show FUT1 Antibodies) homeostasis, which is at least partially regulated through BAF180-mediated suppression of cell cycle regulator p21 (show D4S234E Antibodies) expression.
Data demonstrate a function for BAF180 in promoting genome stability that is distinct from its well-characterized role in transcriptional regulation.
BAF180 is a repressor of IL-10 (show IL10 Antibodies) transcription in Th2 cells and suggest that the differential recruitment of different SWI (show SMARCA1 Antibodies)/SNF (show SNRPA Antibodies) subtypes can have direct consequences on chromatin structure and gene transcription.
BAF180 is critical for coronary vessel formation.
This locus encodes a subunit of ATP-dependent chromatin-remodeling complexes. The encoded protein has been identified as in integral component of complexes necessary for ligand-dependent transcriptional activation by nuclear hormone receptors. Mutations at this locus have been associated with primary clear cell renal cell carcinoma.
, protein polybromo-1
, BRG1-associated factor 180
, glutamate receptor interacting protein 2
, polybromo 1 protein